23 research outputs found
Biological impact assessment of nanomaterial used in nanomedicine. introduction to the NanoTEST project.
Therapeutic nanoparticles (NPs) are used in nanomedicine as drug carriers or imaging agents, providing increased selectivity/specificity for diseased tissues. The first NPs in nanomedicine were developed for increasing the efficacy of known drugs displaying dose-limiting toxicity and poor bioavailability and for enhancing disease detection. Nanotechnologies have gained much interest owing to their huge potential for applications in industry and medicine. It is necessary to ensure and control the biocompatibility of the components of therapeutic NPs to guarantee that intrinsic toxicity does not overtake the benefits. In addition to monitoring their toxicity in vitro, in vivo and in silico, it is also necessary to understand their distribution in the human body, their biodegradation and excretion routes and dispersion in the environment. Therefore, a deep understanding of their interactions with living tissues and of their possible effects in the human (and animal) body is required for the safe use of nanoparticulate formulations. Obtaining this information was the main aim of the NanoTEST project, and the goals of the reports collected together in this special issue are to summarise the observations and results obtained by the participating research teams and to provide methodological tools for evaluating the biological impact of NPs
Influence of organ motion on conformal vs. intensity-modulated pelvic radiotherapy for prostate cancer
publishedVersio
High throughput toxicity screening and intracellular detection of nanomaterials
EC FP7 NANoREG (Grant Agreement NMP4-LA-2013-310584)Free PMC Article: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215403/With the growing numbers of nanomaterials (NMs), there is a great demand for
rapid and reliable ways of testing NM safety—preferably using in vitro
approaches, to avoid the ethical dilemmas associated with animal research. Data
are needed for developing intelligent testing strategies for risk assessment of
NMs, based on grouping and read-across approaches. The adoption of high
throughput screening (HTS) and high content analysis (HCA) for NM toxicity
testing allows the testing of numerous materials at different concentrations and
on different types of cells, reduces the effect of inter-experimental variation, and
makes substantial savings in time and cost.info:eu-repo/semantics/publishedVersio
Towards an alternative testing strategy for nanomaterials used in nanomedicine: lessons from NanoTEST.
In spite of recent advances in describing the health outcomes of exposure to nanoparticles (NPs), it still remains unclear how exactly NPs interact with their cellular targets. Size, surface, mass, geometry, and composition may all play a beneficial role as well as causing toxicity. Concerns of scientists, politicians and the public about potential health hazards associated with NPs need to be answered. With the variety of exposure routes available, there is potential for NPs to reach every organ in the body but we know little about the impact this might have. The main objective of the FP7 NanoTEST project ( www.nanotest-fp7.eu ) was a better understanding of mechanisms of interactions of NPs employed in nanomedicine with cells, tissues and organs and to address critical issues relating to toxicity testing especially with respect to alternatives to tests on animals. Here we describe an approach towards alternative testing strategies for hazard and risk assessment of nanomaterials, highlighting the adaptation of standard methods demanded by the special physicochemical features of nanomaterials and bioavailability studies. The work has assessed a broad range of toxicity tests, cell models and NP types and concentrations taking into account the inherent impact of NP properties and the effects of changes in experimental conditions using well-characterized NPs. The results of the studies have been used to generate recommendations for a suitable and robust testing strategy which can be applied to new medical NPs as they are developed
Mutagenic and carcinogenic potential of metal nanoparticles depends on their physicochemical properties
Invited lectureNanomaterials (NMs) and nanoparticles (NPs) have been studied intensively for almost two decades and still all the characteristics that might be beneficial or harmful are not explored. Although many studies have investigated the mechanisms of action of NPs in cells, results are not fully understood and in many cases are controversial. Endpoints appropriate for detecting harmful chemicals such as cytotoxicity, oxidative stress, inflammation, immunotoxicity, genotoxicity, and in some cases carcinogenicity, have been addressed. However, there might be also new mechanisms that might lead to NM-induced toxic effects.EC FP7 QualityNano (INFRA-2010-1.131-214547-2), FP7 NANoREG (NMP4-LA-2013-310584), FP7 MC (PITN-GA-2010-264506), NRC (239199/O70)N/
Fibrous shape underlies the mutagenic and carcinogenic potential of nanosilver while surface chemistry affects the biosafety of iron oxide nanoparticles
Nowadays engineered nanomaterials (ENMs) are increasingly used in a wide range of
commercial products and biomedical applications. Despite this, the knowledge of human
potential health risk as well as comprehensive biological and toxicological information
is still limited. We have investigated the capacity of two frequently used metallic ENMs,
nanosilver and magnetite nanoparticles (MNPs), to induce thymidine kinase (Tk+/−) mutations
in L5178Y mouse lymphoma cells and transformed foci in Bhas 42 cells. Two types of
nanosilver, spherical nanoparticles (AgNM300) and fibrous (AgNM302) nanorods/wires,
and MNPs differing in surface modifications [MNPs coated with sodium oleate (SO-MNPs),
MNPs coated with SO + polyethylene glycol (SO-PEG-MNPs) and MNPs coated with SO
+ PEG + poly(lactide-co-glycolic acid) SO-PEG-PLGA-MNPs] were included in this study.
Spherical AgNM300 showed neither mutagenic nor carcinogenic potential. In contrast, silver
nanorods/wires (AgNM302) increased significantly the number of both gene mutations and
transformed foci compared with the control (untreated) cells. Under the same treatment
conditions, neither SO-MNPs nor SO-PEG-PLGA-MNPs increased the mutant frequency
compared with control cells though an equivocal mutagenic effect was estimated for SOPEG-
MNPs. Although SO-MNPs and SO-PEG-MNPs did not show any carcinogenic potential,
SO-PEG-PLGA-MNPs increased concentration dependently the number of transformed foci
in Bhas 42 cells compared with the control cells. Our results revealed that fibrous shape
underlies the mutagenic and carcinogenic potential of nanosilver while surface chemistry
affects the biosafety of MNPs. Considering that both nanosilver and MNPs are prospective
ENMs for biomedical applications, further toxicological evaluations are warranted to assess
comprehensively the biosafety of these nanomaterials.FP7 NANoREG (Grant Agreement No. NMP4-LA-2013–310584); FP7 QualityNano (Grant Agreement No: INFRA-2010–262163)info:eu-repo/semantics/publishedVersio
Suitability of human and mammalian cells of different origin for the assessment of genotoxicity of metal and polymeric engineered nanoparticles.
Nanogenotoxicity is a crucial endpoint in safety testing of nanomaterials as it addresses potential mutagenicity, which has implications for risks of both genetic disease and carcinogenesis. Within the NanoTEST project, we investigated the genotoxic potential of well-characterised nanoparticles (NPs): titanium dioxide (TiO2) NPs of nominal size 20 nm, iron oxide (8 nm) both uncoated (U-Fe3O4) and oleic acid coated (OC-Fe3O4), rhodamine-labelled amorphous silica 25 (Fl-25 SiO2) and 50 nm (Fl-50 SiO) and polylactic glycolic acid polyethylene oxide polymeric NPs - as well as Endorem® as a negative control for detection of strand breaks and oxidised DNA lesions with the alkaline comet assay. Using primary cells and cell lines derived from blood (human lymphocytes and lymphoblastoid TK6 cells), vascular/central nervous system (human endothelial human cerebral endothelial cells), liver (rat hepatocytes and Kupffer cells), kidney (monkey Cos-1 and human HEK293 cells), lung (human bronchial 16HBE14o cells) and placenta (human BeWo b30), we were interested in which in vitro cell model is sufficient to detect positive (genotoxic) and negative (non-genotoxic) responses. All in vitro studies were harmonized, i.e. NPs from the same batch, and identical dispersion protocols (for TiO2 NPs, two dispersions were used), exposure time, concentration range, culture conditions and time-courses were used. The results from the statistical evaluation show that OC-Fe3O4 and TiO2 NPs are genotoxic in the experimental conditions used. When all NPs were included in the analysis, no differences were seen among cell lines - demonstrating the usefulness of the assay in all cells to identify genotoxic and non-genotoxic NPs. The TK6 cells, human lymphocytes, BeWo b30 and kidney cells seem to be the most reliable for detecting a dose-response
Minimal analytical characterization of engineered nanomaterials needed for hazard assessment in biological matrices.
Abstract This paper presents the outcomes from a workshop of the European Network on the Health and Environmental Impact of Nanomaterials (NanoImpactNet). During the workshop, 45 experts in the field of safety assessment of engineered nanomaterials addressed the need to systematically study sets of engineered nanomaterials with specific metrics to generate a data set which would allow the establishment of dose-response relations. The group concluded that international cooperation and worldwide standardization of terminology, reference materials and protocols are needed to make progress in establishing lists of essential metrics. High quality data necessitates the development of harmonized study approaches and adequate reporting of data. Priority metrics can only be based on well-characterized dose-response relations derived from the systematic study of the bio-kinetics and bio-interactions of nanomaterials at both organism and (sub)-cellular levels. In addition, increased effort is needed to develop and validate analytical methods to determine these metrics in a complex matrix